Neonc Technologies (NASDAQ:NTHI) Upgraded to Hold at Zacks Research

Neonc Technologies (NASDAQ:NTHI) was upgraded by equities researchers at Zacks Research to a “hold” rating in a report released on Wednesday,Zacks.com reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Neonc Technologies in a report on Monday, December 29th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce”.

Neonc Technologies Stock Performance

NASDAQ:NTHI opened at $8.70 on Wednesday. Neonc Technologies has a 52 week low of $3.20 and a 52 week high of $25.00. The stock’s 50-day moving average price is $8.76 and its 200-day moving average price is $8.08.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.45) EPS for the quarter.

Insider Buying and Selling at Neonc Technologies

In related news, President Amir F. Heshmatpour acquired 6,000 shares of the stock in a transaction that occurred on Monday, November 24th. The stock was purchased at an average price of $6.51 per share, with a total value of $39,060.00. Following the transaction, the president owned 2,992,000 shares of the company’s stock, valued at approximately $19,477,920. This trade represents a 0.20% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have bought 31,100 shares of company stock worth $192,099 in the last ninety days.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of NTHI. Bank of America Corp DE raised its holdings in shares of Neonc Technologies by 1.0% in the 3rd quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock valued at $2,056,000 after buying an additional 2,207 shares during the period. Westmount Partners LLC grew its position in Neonc Technologies by 7.7% in the 4th quarter. Westmount Partners LLC now owns 43,320 shares of the company’s stock valued at $358,000 after acquiring an additional 3,112 shares in the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Neonc Technologies during the third quarter worth about $100,000. SLT Holdings LLC acquired a new stake in shares of Neonc Technologies during the third quarter worth about $100,000. Finally, HCR Wealth Advisors purchased a new position in shares of Neonc Technologies in the second quarter valued at approximately $54,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.